This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.
The focus of the subsequent three meetings was the examination of conditions under consideration for addition to the list of debilitating conditions that are qualifying for participation in the Medical Cannabis Patient Program (MCPP). Those recommendations are being reviewed by the IDPH director’s office.”
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
In the Texas State Capitol Building, dozens of patients joined us to ask their legislators to coauthor legislation that makes the Texas Compassionate Use Program more inclusive and effective. Patients then broke out into groups by district and went to visit their legislative offices. Stay tuned to watch the hearing.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Additional information is available from the NORML fact-sheet , ‘Relationship Between Marijuana and Opioids.’
MCAB members voted to recommend Uterine Fibroid and Painful Uterine Fibroid but did not recommend Generalized Anxiety as a qualifying debilitating condition. After back-and-forth discussion, board members first voted 7-0 to approve Uterine Fibroid as a qualifying debilitating condition. Subieta Benito abstained from the vote.
Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis. Democratic Gov.
During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
The CDC’s interest in alternative methods of chronic pain management is likely to be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
IDFPR is also committed to working with those who received Conditional Adult Use Dispensing Organization licenses in 2023’s Social Equity Criteria Lottery to open their doors as new dispensaries and begin serving customers. Find detailed information about this topic here.) For more information on News Joint Bar Service, visit here.
Published in Nature Partner Journals and sponsored by the Parkinson’s Foundation, the study found that nearly 25% of Parkinson’s patients had used cannabis in the past six months, but that one in four of that group did not know what type or form of cannabis they used, and nearly half did not know their dosage. Of the 43.9% Of the 43.9%
A mind-blowing study from 2024 showed that more than 70% of patients using medical marijuana saw major improvements in managing chronic conditions. Now, let’s dive into the top 10 medical conditions where medical marijuana is having the biggest impact! Medical marijuana is totally shaking up the healthcare scene!
MCAB members focused on the re-introduction of board members, board procedures, updates, and a framework for reviewing evidence for proposed new qualifying conditions. Dr. Temple also presented a mini-review discussion about evidence for accepting and denying new medical conditions. 1-31, 2026.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
December 2022, I published a 6-part series titled, “What Illinois cannabis patients really want” to start a dialogue about the large gap between patients’ needs, wishes, concerns, and recommendation for improving the Medical Cannabis Patient Program (MCPP) and the actual amendments to the law legislators have introduced.
Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day. Transfering nurses’ skills to cannabis medicine.
Study Finds CBD Safe and Promising For Breast Cancer Patients. The use of cannabidiol (CBD), a non-psychoactive compound derived from cannabis, is becoming increasingly popular among patients seeking alternative or complementary treatments for chronic conditions, including cancer. Read More
Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. million patients in 2022, a sharp increase from the 3.1 million patients in 2022, a sharp increase from the 3.1 The study also analyzed peoples’ reasons for registering.
For more information on this bill and to send a message to your State Senator in support of this legislation, click here. For more information on this bill and to send a message to your State Senator in support of this legislation, click here. It passed the House on 2/27/2019 by a vote of 209-147. — Bipartisan bill HB.
Medical marijuana (MMJ) dispensaries play a crucial role in providing patients with access to the cannabis products they need for managing various health conditions. Visiting an MMJ dispensary comes with a set of unwritten rules and etiquettes that patients should be aware of. This is a legal requirement in many states.
House Bill 1283 permits physician assistants to recommend cannabis to qualified patients. House Bill 1417 permits patients with cancer to possess enhanced amounts of cannabis flower (up to six ounces) when explicitly authorized by a recommending health care provider.
This blog was originally written by Anthony Dutcher but has been updated with new information as states continue to change their regulations nationwide. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . These conditions are: Cancer.
As the study authors stated: The wider availability [of marijuana] means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.
“I’ve watched patients walk through my door carrying not just physical pain, but the weight of cultural stigma, family concerns, and years of medical dismissal,” Dr. Fandino-Sende shares. That’s about reconnection to what makes life worth living,” he explains, pausing to show a patient how to adjust their dosage.
Part I of this series detailed the difficult, time consuming, and courageous work behind the process of how the Illinois Department of Public Health (IDPH) added female orgasmic disorder to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program.
Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. Behind the effectiveness of cannabis lies a fascinating biological system known as the endocannabinoid system (ECS). What is ECS?
With a growing number of New Jersey MMJ dispensaries offering a wide range of cannabis products, it’s essential for MMJ patients to stay informed about the options available. Patients can now access a wide variety of cannabis products to address their medical needs. They offer a variety of strains and product options.
Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions. A copy of the bill is available here.
If passed, vaporizable dried raw cannabis would be included with the products available to Iowas medical patients. Companies & Iowa Patients Are Hopeful For Change Lucas Nelson, president of MedPharm Iowa, owns and operates Bud & Marys Cannabis in the state. Theres a patient who visits us from just outside of Ottumwa.
A new patient network, NOPAIN has been set up with the aim of uniting patients to discuss issues surrounding safe, legal cannabis access. When the mould issue occurred, this caused quite a big issue for myself because I’m suspected to have an autoimmune condition that I’m trying to get diagnosed. Writes Cannabis Health News.
And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. I have many patients that want to use cannabis, and they who ask me what product should they get? You can’t say that about most other medicines.
In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.
As medical marijuana gains acceptance in mainstream medicine, patients and healthcare providers need to be well-informed about the various strains available and their unique effects on the body. United Patients Group specializes in providing reliable insights into the therapeutic use of medical marijuana and related plant medicine.
In recognition of this information, a significant but still limited number of Parkinson’s patients have turned to cannabis as a complementary therapy to traditional pharmaceutical options. A survey of current […].
Instead of directly surveying the young patients, they reached out to their caregivers – the individuals who deeply understand the daily routines, challenges, and treatments of these children. This methodology provided valuable real-world information about how CBD is actually applied and received within the CP pediatric community.
Once medical marijuana is ingested, the receptors are opened and the medication begins to provide relief to patients. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. Other debilitating conditions*. Information courtesy of [link].
By the end of 2018 there were almost 60,000 patients, and nearly $100 million had been taken in the first year of sales. It is projected that there will soon be over 200,000 registered medical marijuana patients in Maryland. What Are The Qualifying Conditions For Medical Marijuana In Maryland? Wasting syndrome. Wasting syndrome.
In this article, we’ll closely examine this fascinating exploration of cutting-edge research and learn how this study could transform the future of pain relief for spinal cord injury patients. Persistent pain is a prevalent issue among SCI patients, with nearly 80% of affected individuals experiencing some degree of discomfort.
For conditions like anxiety and PTSD, certain strains with higher CBD content may provide calming effects without the psychoactive properties associated with THC. The endocannabinoid system and mental health How does medical marijuana affect mood disorders and other mental health conditions?
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content